Dr. Vivek T. Malhotra, MD

Dr. Malhotra practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Malhotra's NPI, 1609846120, was assigned on January 26, 2006. Dr. Malhotra graduated from University of Maryland School of Medicine in 1993. Dr. Malhotra holds New York license 206514.

Dr. Malhotra's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Malhotra's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Malhotra to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malhotra practices, 6 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Malhotra's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Malhotra is licensed in New York.

CMS data shows 122 Medicare services from Dr. Malhotra across 2 procedure codes in 2024, for 137 Medicare patients. Medicare paid $8,710 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Malhotra in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malhotra's median patient age at 55, with 68% women.

In 2024, Dr. Malhotra wrote 237 Medicare Part D claims for 56 patients. 76% of them were for generic drugs. CMS names the drug for 160 of them, across 7 drugs with 11 or more claims each, at $48,507 in total drug cost. In 2023, CMS named 179 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Malhotra for performance year 2024, reported as part of a group. Dr. Malhotra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malhotra as offering telehealth.

Dmand AI links 87 papers to Dr. Malhotra, published from 2011 to 2025. 2025 was the busiest year, with 8. The most frequent topics are Endoplasmic Reticulum, Protein Transport and Golgi Apparatus. Dr. Malhotra has published most often in J Cell Biol. Dr. Malhotra's most frequent co-authors are Amitabh Gulati, MD, Mark H. Bilsky, MD and Kenneth H. Cubert, MD.

Dr. Malhotra graduated from University of Maryland School of Medicine in 1993.